Literature DB >> 27862692

PPARγ agonism attenuates cocaine cue reactivity.

William R Miller1,2,3, Robert G Fox2,4, Sonja J Stutz2,4, Scott D Lane5, Larry Denner2,3,6, Kathryn A Cunningham2,3,4, Kelly T Dineley1,2,3.   

Abstract

Cocaine use disorder is a chronic relapsing condition characterized by compulsive drug seeking and taking even after prolonged abstinence periods. Subsequent exposure to drug-associated cues can promote intense craving and lead to relapse in abstinent humans and rodent models. The responsiveness to these cocaine-related cues, or 'cue reactivity', can trigger relapse and cocaine-seeking behaviors; cue reactivity is measurable in cocaine-dependent humans as well as rodent models. Cue reactivity is thought to be predictive of cocaine craving and relapse. Here we report that PPARγ agonism during abstinence from cocaine self-administration reduced previously active lever pressing in Sprague Dawley rats during cue-reactivity tests, while administration of the PPARγ antagonist, GW9662, reversed this effect. PPARγ agonism also normalized nuclear ERK activity in the medial prefrontal cortex and hippocampus which was reversed with GW9662. Our results support the utility of PPARγ agonism as a relapse prevention strategy to maintain abstinence in the presence of cocaine-associated cues.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  ERK MAPK; hippocampus; pioglitazone; prefrontal cortex; relapse prevention

Mesh:

Substances:

Year:  2016        PMID: 27862692      PMCID: PMC5581276          DOI: 10.1111/adb.12471

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  74 in total

1.  Meta-analysis of cue-reactivity in addiction research.

Authors:  B L Carter; S T Tiffany
Journal:  Addiction       Date:  1999-03       Impact factor: 6.526

2.  Chronic cocaine administration causes extensive white matter damage in brain: diffusion tensor imaging and immunohistochemistry studies.

Authors:  Ponnada A Narayana; Juan J Herrera; Kurt H Bockhorst; Emilio Esparza-Coss; Ying Xia; Joel L Steinberg; F Gerard Moeller
Journal:  Psychiatry Res       Date:  2014-01-23       Impact factor: 3.222

3.  Incubation of cue-induced cigarette craving during abstinence in human smokers.

Authors:  Gillinder Bedi; Kenzie L Preston; David H Epstein; Stephen J Heishman; Gina F Marrone; Yavin Shaham; Harriet de Wit
Journal:  Biol Psychiatry       Date:  2011-04-01       Impact factor: 13.382

4.  Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status.

Authors:  Jennifer Rodriguez-Rivera; Larry Denner; Kelly T Dineley
Journal:  Behav Brain Res       Date:  2010-08-13       Impact factor: 3.332

5.  Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity.

Authors:  Susan M Ferguson; Stefania Fasano; Pengwei Yang; Riccardo Brambilla; Terry E Robinson
Journal:  Neuropsychopharmacology       Date:  2006-01-11       Impact factor: 7.853

6.  Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice.

Authors:  Miroslav N Nenov; Fernanda Laezza; Sigmund J Haidacher; Yingxin Zhao; Rovshan G Sadygov; Jonathan M Starkey; Heidi Spratt; Bruce A Luxon; Kelly T Dineley; Larry Denner
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

7.  Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence.

Authors:  Noelle C Anastasio; Sonja J Stutz; Robert G Fox; Robert M Sears; Ronald B Emeson; Ralph J DiLeone; Richard T O'Neil; Latham H Fink; Dingge Li; Thomas A Green; F Gerard Moeller; Kathryn A Cunningham
Journal:  Neuropsychopharmacology       Date:  2013-08-13       Impact factor: 7.853

8.  Perinatal protein deprivation facilitates accumbal ERK phosphorylation in cocaine-sensitized adult rats.

Authors:  E E Velazquez; A Valdomero; N M Maldonado; O A Orsingher; G R Cuadra
Journal:  Behav Brain Res       Date:  2012-12-21       Impact factor: 3.332

Review 9.  Role of corticostriatal circuits in context-induced reinstatement of drug seeking.

Authors:  Nathan J Marchant; Konstantin Kaganovsky; Yavin Shaham; Jennifer M Bossert
Journal:  Brain Res       Date:  2014-09-06       Impact factor: 3.252

10.  Inhibitory behavioral control: A stochastic dynamic causal modeling study comparing cocaine dependent subjects and controls.

Authors:  Liangsuo Ma; Joel L Steinberg; Kathryn A Cunningham; Scott D Lane; James M Bjork; Harshini Neelakantan; Amanda E Price; Ponnada A Narayana; Thomas R Kosten; Antoine Bechara; F Gerard Moeller
Journal:  Neuroimage Clin       Date:  2015-03-24       Impact factor: 4.881

View more
  14 in total

1.  Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor.

Authors:  Christopher T Wild; Joanna M Miszkiel; Eric A Wold; Claudia A Soto; Chunyong Ding; Rachel M Hartley; Mark A White; Noelle C Anastasio; Kathryn A Cunningham; Jia Zhou
Journal:  J Med Chem       Date:  2018-04-13       Impact factor: 7.446

2.  PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Wei-Chun J Hsu; Norelle C Wildburger; Sigmund J Haidacher; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya K Singh; Brent C Chesson; Whitney F Franklin; Ibdanelo Cortez; Rovshan G Sadygov; Kelly T Dineley; Jay S Rudra; Giulio Taglialatela; Cheryl F Lichti; Larry Denner; Fernanda Laezza
Journal:  Exp Neurol       Date:  2017-05-15       Impact factor: 5.330

3.  A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder.

Authors:  Andrea L Dimet; Irma E Cisneros; Robert G Fox; Sonja J Stutz; Noelle C Anastasio; Kathryn A Cunningham; Kelly T Dineley
Journal:  J Vis Exp       Date:  2018-06-18       Impact factor: 1.355

4.  Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission.

Authors:  Esi Domi; Francesca Felicia Caputi; Patrizia Romualdi; Ana Domi; Giulia Scuppa; Sanzio Candeletti; Alison Atkins; Markus Heilig; Gregory Demopulos; George Gaitanaris; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  J Neurosci       Date:  2019-11-04       Impact factor: 6.167

5.  Targeting white matter neuroprotection as a relapse prevention strategy for treatment of cocaine use disorder: Design of a mechanism-focused randomized clinical trial.

Authors:  Joy M Schmitz; Scott D Lane; Michael F Weaver; Ponnada A Narayana; Khader M Hasan; DeLisa D Russell; Robert Suchting; Charles E Green
Journal:  Contemp Clin Trials       Date:  2021-10-22       Impact factor: 2.226

6.  Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder.

Authors:  Jennifer R Schroeder; Karran A Phillips; David H Epstein; Michelle L Jobes; Melody A Furnari; Ashley P Kennedy; Markus Heilig; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2018-08-06       Impact factor: 4.530

Review 7.  Glial and neuroinflammatory targets for treating substance use disorders.

Authors:  Ryan K Bachtell; Jermaine D Jones; Keith G Heinzerling; Patrick M Beardsley; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

8.  Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential.

Authors:  Jermaine D Jones; Sandra D Comer; Verena E Metz; Jeanne M Manubay; Shanthi Mogali; Roberto Ciccocioppo; Suky Martinez; Mudassir Mumtaz; Adam Bisaga
Journal:  Pharmacol Biochem Behav       Date:  2017-10-08       Impact factor: 3.533

9.  Andrographis paniculata and Its Main Bioactive Ingredient Andrographolide Decrease Alcohol Drinking and Seeking in Rats Through Activation of Nuclear PPARγ Pathway.

Authors:  Serena Stopponi; Yannick Fotio; Carlo Cifani; Hongwu Li; Carolina L Haass-Koffler; Nazzareno Cannella; Gregory Demopulos; George Gaitanaris; Roberto Ciccocioppo
Journal:  Alcohol Alcohol       Date:  2021-02-24       Impact factor: 2.826

10.  Beta-caryophyllene inhibits cocaine  addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder.

Authors:  Ewa Galaj; Guo-Hua Bi; Allamar Moore; Kai Chen; Yi He; Eliot Gardner; Zheng-Xiong Xi
Journal:  Neuropsychopharmacology       Date:  2020-10-17       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.